Diffuse Large B-Cell Lymphoma — Trials

Diffuse Large B-Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

1,150 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 355
Recruiting: 190
Ph III recruiting: 16
Growth YoY: −11.6%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (177)

clinicaltrialsPublishedShowing 101–117 of 117 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06701357	CR-CHOP+X in Previously Untreated DEL	recruiting	Phase 2	49	Ruijin HospitalOTHER	1	Dec 30, 2024	clinicaltrials
NCT06674096	RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL	recruiting	Phase 2	44	Zhejiang Cancer HospitalOTHER	1	Nov 18, 2024	clinicaltrials
NCT06683885